Health Biotech Limited
Sector 34A, Chandigarh
SEND SMS
SEND EMAIL
Product Details:
| Usage | Hospital, Clinical |
| Composition : | 100mg/ ml (100ml pack) |
| Indications : | Treatment of partial onset seizures in adults with epilepsy. |
| Contraindications : | Hypersensitivitiy to levetiracetam or other pyrrolidone derivatives. |
| Safety Profile : | Should be withdrawn gradually to minimize the potential of increased seizure frequency. Caution required in patient with moderate and severe renal impairment and patients undergoing hemodialysis. Assessment of renal function is recommended before selection. Driving or operating machinery is not recommended. |
| Adverse Effects : | Headache, anxiety, depression, dizziness, somnolence, increase cough, convulsion, vertigo, hallycination, irritability psychotic disorder, thromobocytopenia, neutropenia, leukopenia. |
| Drug Interactions: | It does not influence the plasma concentration of existing AEDs (like phenytoin)and these AEDs do not influence the pharma cokinetics of levetiracetam. |
| Dosage : | Intial dose 1000 mg / day B.I.D depending upon the tolerance and response. Incremental dose is 1000 mg day additional every 2 weeks. Maximum doses 3000 mg / day. Dose should be withdraw gradually e.g . 500 mg twice daily decrements every 2-4 weeks. |
| Purity : | Not less than 99%. |
Product Details:
| Usage | Clinical |
Product Details:
| Prescription/Non prescription | Prescription |
| Also gives | PCD Pharma Franchise, Third Party Manufacturing |
| Form | Injection |
